RT Journal Article
SR Electronic
T1 A Long COVID Risk Predictor Focused on Clinical Workflow Integration
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.26.23290243
DO 10.1101/2023.05.26.23290243
A1 Bhattacharya, Biplab S.
A1 Mitchell, Elliot G.
A1 Shetty, Gaurav
A1 Delong, Grant
A1 Munia, Tamanna T. K.
A1 Tariq, Abdul A.
YR 2023
UL http://medrxiv.org/content/early/2023/05/26/2023.05.26.23290243.abstract
AB For the NIH Long COVID Computational Challenge (L3C) in the Fall of 2022, we developed a machine learning model to predict who is at high risk for developing Long COVID, optimized for clinical deployment. Our submission won second prize in the competition. We present lessons learned, with details on the features, model selection and performance, fairness analysis, limitations, and deployment implications.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding. The study received an award from the NIH/N3C for a second place prize in the L3C.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Geisinger waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data used in the present study were made available through the NIH National COVID Cohort Collaborative (N3C) as a part of the Long COVID Computational Challenge (L3C) https://github.com/geisinger-ai-lab/gail-l3c